ПБиМ 2023 №2 (143)

Subject of the article

АУТОИММУННЫЕ ЗАБОЛЕВАНИЯ, АССОЦИИРОВАННЫЕ С ПРЕЖДЕВРЕМЕННОЙ НЕДОСТАТОЧНОСТЬЮ ЯИЧНИКОВ (266-271)

Authors

Фахрутдинова С.С.

Institution

Республиканский специализированный научно-практический медицинский центр эндокринологии им. акад. Ё.Х. Туракулова

Abstract

Представлен обзор литературы, раскрывающий значение аутоиммунных заболеваний в патогенезе преждевременной недостаточности яичников. В настоящее время причины развития заболевания до конца не установлены, но до 30% случаев связаны с аутоиммунными заболеваниями, специфичными для различных органов.

Key words

преждевременная недостаточность яичников, аутоиммунные заболевания щитовидной железы, аутоиммунные полиэндокринные синдромы, преждевременная недостаточность яичников, антитела к ткани яичников, антитела к яичникам.

Literature

1. Bakalov V., Vanderhoof V., Bondy C., Nelson L. Adrenal antibodies detect asymptomatic auto-immune adrenal insufficiency in young women with spontaneous premature ovarian failure. Hum. Reprod. 2002; 17: 2096–2100. 2. Bano G., Mansour S., Nussey S. The association of primary hyperparathyroidism and primary ovarian failure: A de novo t(X, 2) (q22p13) reciprocal translocation. Eur. J. Endocrinol. 2008; 158: 261–263. 3. De Bellis A., Bellastella G., Falorni A. et al. Natural history of autoimmune primary ovarian insufficiency in patients with Addison’s disease: From normal ovarian function to overt ovarian dysfunction. Eur. J. Endocrinol. 2017; 177: 329–337. 4. De Vos M., Devroey P., Fauser B. Primary ovarian insufficiency. Lancet 2010; 376: 911–921. 5. Ebrahimi M., Asbagh F.A. Pathogenesis and Causes of Premature Ovarian Failure: An Update. Int. J. Fertil. Steril. 2011; 5: 54–65. 6. Ebrahimi M., Akbari Asbagh F. The role of autoimmunity in premature ovarian failure. Iran J Reprod Med. 2015; 13(8): 461-472. 7. Forges T., Monnier-Barbarino P., Faure G., Bene, M.C. Autoimmunity and antigenic targets in ovarian pathology. Hum. Reprod. Updat. 2004; 10: 163–175. 8. Goswami D., Conway G. Premature ovarian failure. Hum Reprod Update 2005; 11: 391–410. 9. Goswami R., Marwaha R., Goswami D. et al. Prevalence of Thyroid Autoimmunity in Sporadic Idiopathic Hypoparathyroidism in Comparison to Type 1 Diabetes and Premature Ovarian Failure. J. Clin. Endocrinol. Metab. 2006; 91: 4256–4259. 10. Grossmann B., Saur S., Rall K. et al. Prevalence of autoimmune disease in women with premature ovarian failure. Eur. J. Contracept. Reprod. Health Care 2019; 25: 72–75. 11. Gunning M., Meun C., Van Rijn B. et al. Coronary artery calcification in middle-aged women with premature ovarian insufficiency. Clin. Endocrinol. 2019; 91: 314–322. 12. Hollowell J., Staehling N., Flanders W. et al. Serum TSH, T4, and Thyroid Antibodies in the United States Population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J. Clin. Endocrinol. Metab. 2002; 87: 489–499. 13. Komorowska B. Autoimmune premature ovarian failure. Menopausal Rev. 2016; 4: 210–214. 14. Kulaksizoglu M., Ipekci S., Kebapcilar L. et al. Risk Factors for Diabetes Mellitus in Women with Primary Ovarian Insufficiency. Biol. Trace Element Res. 2013; 154: 313–320. 15. Kumar N., Manesh I. Premature Ovarian Insufficiency: Aetiology and Long-Term Consequences. Women’s Health Open J. 2017; 3, 45–58. 16. La Marca A., Brozzetti A., Sighinolfi G. et al. Primary ovarian insufficiency: Autoimmune causes. Curr. Opin. Obstet. Gynecol. 2010; 22: 277–282. 17. Lewińsk A., Ewa Płaczkiewicz-Jankowska E. APS-III. InInternal Medicine, Medycyna Praktyczna: Kraków, Poland, 2019. 18. Luisi S., Orlandini C., Regini C. et al. Premature ovarian insufficiency: From pathogenesis to clinical management. J. Endocrinol. Investig. 2015; 38:597–603. 19. Nelson L. Clinical practice. Primary ovarian insufficiency. New England Journal of Medicine 2009; 360: 606–614. 20. Osuka S., Iwase A., Goto M. et al. Thyroid Autoantibodies do not Impair the Ovarian Reserve in Euthyroid Infertile Women: A Cross-Sectional Study. Horm. Metab. Res. 2018; 50: 537–542. 21. Perheentupa J. Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy. Journal of Clinical Endocrinology and Metabolism 2006; 91: 2843–2850. 22. Podfigurna-Stopa A., Czyzyk A., Grymowicz M. et al. Premature ovarian insufficiency: The context of long-term effects. J. Endocrinol. Investig. 2016; 39: 983–990. 23. Pra C., Chen S., Furmaniak J. et al. Autoantibodies to steroidogenic enzymes in patients with premature ovarian failure with and without Addison’s disease. Eur. J. Endocrinol. 2003;148: 565–570. 24. Reato G., Morlin L., Chen S. et al. Premature Ovarian Failure in Patients with Autoimmune Addison’s Disease: Clinical, Genetic, and Immunological Evaluation. J. Clin. Endocrinol. Metab. 2011; 96: E1255–E1261. 25. Saari V., Holopainen E., Mäkitie O., Laakso S. Pubertal development and premature ovarian insufficiency in patients with APECED. Eur J Endocrinol. 2020; 183(5): 513-520. 26. Saglam F., Onal E.D., Ersoy R. et al. Anti-Müllerian hormone as a marker of premature ovarian aging in autoimmune thyroid disease. Gynecol. Endocrinol. 2014; 31: 165–168. 27. Sharif K., Watad A., Bridgewood, C. et al. Insights into the autoimmune aspect of premature ovarian insufficiency. Best Pr. Res. Clin. Endocrinol. Metab. 2019; 33: 101323. 28. Silva C., Yamakami L., Aikawa N. et al. Autoimmune primary ovarian insufficiency. Autoimmun. Rev. 2014;13: 427–430. 29. Szeliga A., Calik-Ksepka A, Maciejewska-Jeske M. et al. Autoimmune Diseases in Patients with Premature Ovarian Insufficiency-Our Current State of Knowledge. Int J Mol Sci. 2021; 22(5): 2594. 30. Szlendak-Sauer K., Jakubik D., Kunicki M., et al. Autoimmune polyglandular syndrome type 3 (APS-3) among patients with premature ovarian insufficiency (POI). Eur. J. Obstet. Gynecol. Reprod. Biol. 2016; 203: 61–65. 31. Webber L., Davies M., Anderson R. et al. ESHRE Guideline: management of women with premature ovarian insufficiency. Human Reproduction. 2016; 31(5): 926–937. 32. Welt C. Autoimmune Oophoritis in the Adolescent. Ann. N. Y. Acad. Sci. 2008; 1135: 118–122.